Cerebral, the controversial psychological telehealth startup, filed a lawsuit in New York on Monday alleging that founder Kyle Robertson by no means repaid a mortgage the corporate gave him for practically $50 million.
Cerebral alleges it lent Robertson $49,768,453.79 on Jan 24, 2022, permitting him to buy practically 1.06 million shares of Cerebral inventory. In accordance with a submitting within the New York State Supreme Court docket for the County of New York, Cerebral alleges Robertson is chargeable for greater than $25 million or 51% of the mortgage principal quantity, plus curiosity and lawyer’s charges.
The corporate alleges Robertson was to repay the mortgage if his time as CEO had been to finish for any purpose inside six months of that termination date. Robertson was pushed out of the corporate in mid-Might after mounting criticism of the startup’s prescribing practices for ADHD, together with three lawsuits by former workers and a federal investigation.
Cerebral alleges that after Robertson was gone as CEO, he stated he wouldn’t repay the mortgage.
Not a Fashionable Healthcare subscriber? Enroll as we speak.
Robertson didn’t reply to a request for remark. Neither a Cerebral spokesperson nor an lawyer representing the corporate had been instantly out there for remark.
The submitting follows a letter Robertson despatched final week demanding entry to the corporate data prematurely of a possible lawsuit. Within the letter, Robertson accused the corporate’s buyers of pushing him to promote managed medicines for consideration deficit hyperactivity dysfunction after which utilizing him as a scapegoat amid public blowback.
Final week, the corporate’s CEO, Dr. David Mou, stated he was not targeted on the scathing letter despatched by Robertson, his former colleague, directed to the corporate’s govt group and buyers.
“It’s a distraction. I’m wanting ahead,” Mou stated in an interview on the HLTH convention in Las Vegas. “I’m right here to deal with our sufferers.”
The contents of Robertson’s letter had been first reported by Enterprise Insider.
A Cerebral spokesperson stated the claims laid out by Robertson had been unfaithful and the corporate intends to defend itself vigorously if a grievance had been filed.
Since Robertson’s departure, the U.S. Federal Commerce Fee reportedly despatched a letter to Cerebral requesting data on whether or not the corporate has continued to cost sufferers even after they’ve tried to cancel their subscription.
Amid the controversy, the corporate stopped prescribing Adderall and Ritalin in Might. On the time Mou stated he was saddened by the choice, as he thought of them respectable first-line therapy for sufferers with ADHD. Cerebral nonetheless prescribes suboxone, a managed substance for opioid use dysfunction, Mou stated.
This story first appeared in Digital Well being Enterprise & Expertise.